Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01174329

Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation (SALELECTROSTIM)

Difference in Salivary Flow in Patients With Salivary Gland Hypofunction of the Following Application of Neuro-electrostimulation

Sponsor: Universidad Autonoma de Nuevo Leon

Conditions Polypharmacy Sjögren's Syndrome Xerostomia

Interventions Automatic neuro-electrostimulation by Saliwell Crown Patient-regulated neuro-electrostimulation by Saliwell Crown

Updated 5 times since 2017 Last updated: Aug 17, 2010 Started: Aug 31, 2010 Primary completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Polypharmacy and Sjögren's Syndrome and is currently ongoing. Universidad Autonoma de Nuevo Leon leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Autonoma de Nuevo Leon

Data source: Universidad Autonoma de Nuevo Leon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monterrey, Mexico